News

Matt Pohlson, 41, is chief executive and co-founder of Omaze, a for-profit online fundraising company in Culver City that raffles off unique celebrity experiences and prizes to support charitable efforts and help fund nonprofits. Click to View Article

Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthma. Recruitment in the trial is underway and the first patient has been enrolled. Click to View Article

Founded in 2015, YieldStreet is a New York-based fintech startup aimed at democratising investment opportunities in non-traditional markets like real estate, marine/shipping, legal finance, commercial loans and more. Click to View Article

Orphan Drug designation allows companies a 7-year marketing exclusivity period, should the treatment be approved. Click to View Article

How would you like to buy lunch with Will Kassoy, the new president of Omaze? I’m just kidding, but Kassoy has joined a company that makes such things possible. Click to View Article

YieldStreet, the alternative investment platform for retail investors, has agreed to acquire Athena Art Finance from the Carlyle Group and its co-investors for $170M. Click to View Article

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson Click to View Article

YieldStreet, the fintech startup bringing alternative investments to the masses, has raised $62 million in financing, led by Edison Partners, the growth equity investment firm. Click to View Article

When YieldStreet launched a $6.45 million offering on its marketplace, it expected a lot of investors to get in on the deal. After all, they had about seventy-two hours to digest all the important aspects of the company and the … Continued